scispace - formally typeset
D

Do Young Kim

Researcher at Yonsei University

Publications -  737
Citations -  18320

Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model.

TL;DR: This novel model accurately estimated the risk of HCC occurrence in patients with chronic hepatitis B and showed good discrimination capability, with an area under the receiver operating characteristic curve (AUROC) of 0.806.
Journal ArticleDOI

Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.

TL;DR: HCC patients with low values of both AFP and PIVKA-II had more favorable clinical characteristics and showed a better prognosis than those with elevated levels of AFP or PIVka-II.
Journal ArticleDOI

Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B.

TL;DR: This study investigated the influence of sarcopenia on liver fibrosis in individuals with chronic hepatitis B and found that sarc Openia is significantly associated with the degree of Liver fibrosis.
Journal ArticleDOI

Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: Endoscopic findings and risk factors

TL;DR: Endoscopically detectable radiation-induced gastroduodenal complications were common in HCC following CCRT and the frequency was higher in patients with liver cirrhosis; thus, these patients should be closely monitored when receiving C CRT.
Journal ArticleDOI

Serum Dickkopf-1 as a Biomarker for the Diagnosis of Hepatocellular Carcinoma

TL;DR: In this paper, the authors investigated whether Dickkopf-1 is related to progression in hepatocellular carcinoma (HCC) cells and HCC patients, and found that DKK-1 was not associated with progression in HCC cells.